We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIXT
3101
DELISTED
MIX TELEMATICS LIMITED
MIXT
$205K ﹤0.01%
13,200
+518
+4% +$7.04K
BX icon
3102
PUT
Blackstone
BX
$113B
$204K ﹤0.01%
21,700
-29,300
-57% -$999K
GUT
3103
Gabelli Utility Trust
GUT
$573M
$204K ﹤0.01%
33,632
+413
+1% +$2.79K
MSI icon
3104
CALL
Motorola Solutions
MSI
$76.5B
$204K ﹤0.01%
119,000
-16,900
-12% -$1.73M
SRE.PRA
3105
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
$204K ﹤0.01%
+1,990
New +$201K
PBFX
3106
DELISTED
PBF LOGISTICS LP
PBFX
$203K ﹤0.01%
10,988
-14,762
-57% -$300K
PHK
3107
PIMCO High Income Fund
PHK
$878M
$202K ﹤0.01%
26,671
-16,039
-38% -$122K
CCA
3108
DELISTED
MFS California Municipal Fund
CCA
$202K ﹤0.01%
+19,353
New +$210K
MVT
3109
DELISTED
BlackRock MuniVest Fund II
MVT
$201K ﹤0.01%
+14,033
New +$211K
AMPE
3110
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$201K ﹤0.01%
197
+85
+76% +$71.2K
MOBL
3111
DELISTED
MobileIron, Inc.
MOBL
$201K ﹤0.01%
40,534
+5,122
+14% +$23.3K
BDCS
3112
DELISTED
UBS AG Exchange Traded Access Securities (E-TRACS)Linked to the Wells Fargo Business Development Com
BDCS
$201K ﹤0.01%
10,161
+8
+0.1% +$159
AAC
3113
DELISTED
AAC Holdings
AAC
$200K ﹤0.01%
17,380
-4,300
-20% -$42.2K
KED
3114
DELISTED
Kayne Anderson Energy
KED
$200K ﹤0.01%
12,822
+238
+2% +$4.08K
CRWS icon
3115
Crown Crafts
CRWS
$32M
$199K ﹤0.01%
33,800
ACOR
3116
CALL
DELISTED
Acorda Therapeutics
ACOR
$199K ﹤0.01%
789
-40
-5% -$120K
FTSI
3117
DELISTED
FTS International, Inc. Common Stock
FTSI
$199K ﹤0.01%
+540
New +$210K
FOMX
3118
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$198K ﹤0.01%
38,500
BSBR icon
3119
Santander
BSBR
$43.1B
$197K ﹤0.01%
+17,126
New +$180K
JHD
3120
DELISTED
Nuveen High Income December 2019 Target Term Fund
JHD
$197K ﹤0.01%
+20,000
New +$198K
CSLT
3121
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$194K ﹤0.01%
53,200
-700
-1% -$2.6K
TOO
3122
DELISTED
Teekay Offshore Partners L.P.
TOO
$192K ﹤0.01%
84,402
-5,018
-6% -$12.8K
ARI
3123
Apollo Commercial Real Estate
ARI
$871M
$191K ﹤0.01%
10,625
-3,000
-22% -$54.9K
CTR
3124
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$191K ﹤0.01%
+3,882
New +$228K
MCBC
3125
DELISTED
Macatawa Bank Corp
MCBC
$191K ﹤0.01%
18,610
-1,000
-5% -$10.2K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.